New therapy improves life span in melanoma patients with brain metastases
In a retrospective study, Saint Louis University researchers have found that patients with melanoma brain metastases can be treated with large doses of interleukin-2 (HD IL-2), a therapy that triggers the body’s own immune system to destroy the cancer cells. John Richart, M.D., associate professor of internal medicine at SLU and principal investigator of the […]
